― Introducing CarbConnect® and DX/AI Solutions for the Life Sciences in New Delhi ―
CarbGeM Inc. (hereinafter “the Company”) exhibited at the Japan Pavilion operated by Medical Excellence JAPAN (MEJ) at “FICCI HEAL 2026,” a healthcare conference organized by the Federation of Indian Chambers of Commerce & Industry (FICCI) and held in New Delhi, India, on October 27–28, 2026. During the conference, Masakazu Nakajima, CEO of the Company, presented at a session featuring Japanese companies on the first day, October 27, and took part as a panelist in the panel discussion “Digital Health at Scale: From Innovation Pilots to Nationwide Impact” on the second day, October 28.
FICCI, the organizer, was founded in 1927 and is the oldest and largest business organization in India. Playing a role similar to that of Keidanren (Japan Business Federation) and the Japan Chamber of Commerce and Industry, FICCI is the leading voice of Indian industry, connected with more than 250,000 companies through regional chambers of commerce and other bodies. FICCI HEAL is an international healthcare conference that FICCI has held every year since 2007. Marking its 20th edition, this year’s conference was held under the theme “HEAL@20: From Vision to Value,” with the support of the Ministry of Health & Family Welfare (MoHFW) and NITI Aayog, the Government of India’s policy think tank. It featured policy roundtables attended by policymakers and senior hospital executives, as well as sessions on healthcare DX and data governance, AI, genomics, and precision medicine. The participation of Japanese companies was supported as part of the ME-India program implemented by MEJ.
At its booth, the Company introduced its DX/AI solutions, including the life science AI platform “CarbConnect®.”

(Photo courtesy of MEJ)
| Name | FICCI HEAL 2026 (20th edition) |
|---|---|
| Theme | HEAL@20: From Vision to Value |
| Dates | Tuesday, October 27 – Wednesday, October 28, 2026 |
| Venue | FICCI Federation House (New Delhi, India) |
| Organizer | Federation of Indian Chambers of Commerce & Industry (FICCI) |
| Supported by | Ministry of Health & Family Welfare and NITI Aayog, Government of India |
| Support for Japanese Companies | Medical Excellence JAPAN (MEJ) (ME-India program) |
| CarbGeM’s Participation | Booth exhibition at the Japan Pavilion / Presentation at the Japanese company presentation session (October 27) / Panelist in a panel discussion (October 28) |
| Official Website | https://health.ficci.in/ |
■ Tuesday, October 27, 12:50–13:15 (IST): Japanese Company Presentations
As one of five Japanese companies supported by MEJ, the Company took the stage in the session “Healthcare Innovations with MEJ- Japan,” part of the HEAL@20 Presentations, and introduced its DX/AI solutions (three minutes per company).
■ Wednesday, October 28, 9:30–10:45 (IST): Panel Discussion
Nakajima joined the panel discussion “Digital Health at Scale: From Innovation Pilots to Nationwide Impact,” part of the HEAL@20 Dialogue Series, as the only panelist from Japan. He was joined by Dr Sujoy Kar, Chief Information Officer (CIO) and Vice President of Apollo Group of Hospitals; Dr Ravi Gaur, Founder of DRG Path Lab; and senior executives from Elekta, Prodoc.AI, and Eshe Fem Health. The session was moderated by Mr Sandeep Jha of KPMG India. The panelists discussed how to scale digital health from the pilot stage to nationwide adoption, covering topics such as interoperability and digital public infrastructure, the digital transformation of hospitals, and cybersecurity and data governance.
We would like to take this opportunity to express our sincere gratitude to Medical Excellence JAPAN (MEJ) for its generous support of our exhibition and presentations, including introductions on site and coordination with stakeholders.
About CarbGeM Inc.
| Item | Details |
|---|---|
| Company Name | CarbGeM Inc. |
| Representative | Masakazu Nakajima, CEO |
| Headquarters | 1-5-13 Jinnan, Shibuya-ku, Tokyo, Japan |
| Founded | March 2021 |
| Business | Development and provision of AI-driven biotechnology solutions for the life sciences sector |
| Website | https://carbgem.com/en/ |
CarbGeM advances diagnostic support, research efficiency, and the standardization and automation of quality control in the life sciences through advanced technologies, backed by achievements that include regulatory approval of Software as a Medical Device (SaMD). By addressing social challenges such as shortages of skilled technicians and regional disparities, the company delivers accurate and rapid results that support medical and industrial settings. CarbGeM has received numerous awards in Japan and abroad: in January 2025, it received an Honorable Mention at the Tokyo Social Innovation Tech Award 2024; in February 2026, it was selected as a Global Top 10 company at the AI Impact Summit 2026 hosted by the Government of India; and in April 2026, it won the Excellence Award in the software category of the 38th Excellent New Technology and New Product Awards for SMEs. The company also continues to pursue open innovation with partners across industry, academia, and government to co-create the future of regional communities, healthcare, and research.